Globus Medical, Inc. · NYSE:GMED
Globus Medical — Merger or Acquisition (February 2023)
20 slides from Globus Medical's merger presentation, Feb 9, 2023
Slide 1: Combining to create an innovative global musculoskeletal company
Combining to create an innovative global musculoskeletal company February 9, 2023 Exhibit 99.1
Slide 2: Legal disclaimers
Legal disclaimers No Offer or Solicitation This communication is for informational purposes only and is not intended to and does not constitute an offer to subscribe for, buy or sell, or the solicitation of an offer to subscribe for, buy or sell, or an invitation to subscribe for, buy or sell any se
Slide 3: Legal disclaimers: Important Information About the Transaction
Legal disclaimers Important Information About the Transaction and Where To Find It In connection with the proposed transaction, Globus Medical will file with the U.S. Securities and Exchange Commission (“SEC”) a registration statement on Form S-4 that will include a joint proxy statement of Globus M
Slide 4: Focused on superior outcomes in patient care
Focused on superior outcomes in patient care Relentless pursuit of unmet clinical needs because today’s outcomes still need to evolve further to advance musculoskeletal care
Slide 5: Value creation for key stakeholders
Value creation for key stakeholders PATIENTS Continued focus on improving patient outcomes Access to best-in-class product portfolio Combined resources for future innovation to solve unmet clinical needs SURGEONS Expands product offerings in procedures and enabling technologies Leverages talent from
Slide 6: Combination creates innovative, global musculoskeletal company
Combination creates innovative, global musculoskeletal company Expands operational capabilities Strong financial profile and value creation opportunity for shareholders Compelling upside revenue potential Complementary global footprint to support more patients and surgeons Comprehensive and innovati
Slide 7: Transaction overview
Transaction overview Structure Stock-for-stock merger NuVasive shareholders will receive a fixed exchange ratio of 0.75 Globus Medical share for each NuVasive share Anticipated Post-Closing Ownership Globus Medical shareholders: 72% NuVasive shareholders: 28% Governance Executive Chairman: David Pau
Slide 8: A shared history of innovation and growth
A shared history of innovation and growth Annual Sales ($M)
Slide 9: $50B total addressable market with multiple high-growth levers
Source: US Dollars Orthopedic Industry Annual Report 2020 (in Billion) 14% Trauma $7B 40% Total Joint Arthroplasty $20B 26% Spine $13B 16% Enabling Tech $8B 4% Power Tools $2B Market $50B total addressable market with multiple high-growth levers
Slide 10: Complementary U.S. commercial organizations
Complementary U.S. commercial organizations Ability to better serve more patients Strong presence coast to coast Exclusive U.S. sales force Limited customer overlap
Slide 11: Accelerates globalization strategies to target and win in high-growth markets
Accelerates globalization strategies to target and win in high-growth markets A combined presence in more than 50 countries Complementary international footprint in key markets Australia/New Zealand, Brazil, Germany, Italy, Japan, U.K. Creates immediate scale globally and ability to effectively inve
Slide 12: Comprehensive portfolio of spine solutions
Globus Medical NuVasive Comprehensive portfolio of spine solutions to help improve patient care Illustrative only – does not include all product offerings XLIF CREO MIS® Fixation System NuVasive ACP system MAGEC system Simplify cervical disc Quartex® Fixation System FORTIFY® Corpectomy System HEDRON
Slide 13: Comprehensive portfolio of orthopedic solutions
Comprehensive portfolio of orthopedic solutions to help improve patient care Illustrative only – does not include all product offerings ANTHEM® Proximal Humerus System ANTHEM® Clavicle Fracture System ANTHEM® Small Fragment Fracture System PROVIDENT® Hip System ANTHEM® Distal Radius System AUTOBAHN®
Slide 14: Positioned to address the continuum of patient care with intelligent surgery
Positioned to address the continuum of patient care with intelligent surgery Intra-op Pre-op Post-op Patient assessment & optimization Procedure selection & planning Procedure execution & verification Healing & recovery monitoring Outcome evaluation & continual learning
Slide 15: Continued commitment to surgeon education and research
Continued commitment to surgeon education and research * Management estimates Surgeon trainings 2,500+ surgeons trained in 2022* Clinical studies, research More than 800 peer reviewed publications and 70+ ongoing clinical studies* SpineTRACK registry Prospective, multicenter, observational data coll
Slide 16: Expands operational expertise
Expands operational expertise Focus on unlocking manufacturing capacity and increasing asset utilization to improve customer service level Leverage NuVasive's ~100,000-square foot Memphis, TN Expertise from Globus Medical's >300,000 square foot manufacturing plants in Limerick, PA, Audubon, PA & San
Slide 17: Employees
Employees Shared commitment to patient-focused innovation Strong sense of urgency Opportunities for career advancement Integrates infrastructure and resources Passionate workforce
Slide 18: Combination creates a compelling financial profile for shareholders
Combination creates a compelling financial profile for shareholders Anticipate above market mid- to high-single digit growth Expected to achieve mid-30s EBITDA* margins by year three ~$170M in cost synergies expected to be achieved by year three Accretive to Non-GAAP EPS* anticipated in the first ye
Slide 19: Our vision
Our vision Diversified, leading musculoskeletal technology company Thought and industry leadership in spine Innovation in imaging, navigation, and robotics Build strong foundation in trauma and total joint arthroplasty Continue to expand in other musculoskeletal areas, including regenerative biologi
Slide 20: Combining to create an innovative, global musculoskeletal company focused on patient care
Combining to create an innovative, global musculoskeletal company focused on patient care Exhibit 99.2
Globus Medical — Merger or Acquisition (February 2023) on 6ix